B. Balbi (Pavia, Italy), J. Braun (Lubeck, Germany)
BAL levels of T1 and T2 cytokines in asthma and COPD
B. Balbi, A. Capelli, A. Di Stefano, M. Lusuardi, M. Delmastro, A. Balestrino, P. Balbo, F. Ioli, G. Brunetti, C. Rampulla, C. F. Donner (Pavia, Veruno, Novara, Italy)
|  |
Interleukin-17 in induced sputum correlates with airway hyperresponsiveness to methacholine
A. Barczyk, W. Pierzchala, E. Sozanska (Katowice, Poland)
| |
Elevated cytokeratin 19 fragment in chronic obstructive pulmonary disease
A. Barczyk, W. Pierzchala, E. Sozanska (Katowice, Poland)
| |
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis
A. Barczyk, W. Pierzchala, E. Sozanska (Katowice, Poland)
| |
Induced sputum versus BAL- differences in the morphology of inflammatory cells
J. J. Domagala-Kulawik, M. Maskey- Warzêchowska, I. Kraszewska, R. Chazan (Warsaw, Poland)
| |
Pathogens influence MMP-TIMP imbalance in nosocomial pneumonia
J. A. Wermelt, C. M. Hartog, H. A. Katus, K. Dalhoff, J. Braun (Lübeck, Germany)
| |
Quantitative cultures of bronchoalveolar lavage fluid during the course of pneumonia
V. Dudzevicius, R. Sakalauskas, A. Vitkauskiene, K. Malakauskas (Kaunas, Lithuania)
| |
Isolation of opportunistic pathogens in fibrebronchoscopy samples of patients with pulmonary involvement of collagen-vascular diseases
A. Hernandez Martinez, J. Martin Juan, C. Rodriguez Matute, J. L. Lopez-Campos, A. Garcia Fernandez, J. Sanchez Roman, E. Rodriguez Becerra, F. Rodriguez Panadero (Sevilla, Spain)
| |
Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD)
S. N. Avdeev, Y. M. Shulagin, O. E. Avdeeva, E. V. Stepanov, A. V. Cherniak, A. G. Chuchalin (Moscow, Russia)
| |
Inhibition of cytokine release from alveolar macrophages in sarcoidosis by pentoxifylline: comparison with dexamethasone
Z. H. Tong, B. M. Chen, H. Dai, J. Guzman, Z. Abdoh, U. Costabel (Essen, Germany)
| |
Cytokine and protein profile in BAL from patients with sarcoidosis and IPF
P. Rottoli, B. Magi, M. G. Perari, N. Nikiforakis, L. Bini, V. Pallini (Siena, Italy)
| |
CD8 BAL lymphocytosis differentiates usual interstitial pneumonia (UIP) from sarcoidosis (SA); correlation with clinical parameters
Z. D. Daniil, M. H. Karatza, N. Kolitza, E. Nikiforakis, J. Milic-Emili, C. Roussos, S. Papiris (Athens, Greece; Montreal, Canada)
| |
Clinical significance of sialyl SSEA-1 (SLX) in patients with idiopathic interstitial pneumonia
Y. Totani, Y. Demura, S. Ameshima, I. Miyomori, T. Ishzaki (Fukui, Japan)
| |
Correlations between high resolution computed tomography (HRCT), pulmonary function tests (PFT), and bronchoalveolar lavage fluid (BALF) cellularity in the interstitial lung disease associated to collagen-vascular diseases
C. Rodriguez Matute, J. Martin Juan, A. Garcia Fernandez, A. Hernandez Martinez, J. L. Lopez-Campos, J. Sanchez-Roman, E. Rodriguez Becerra, F. Rodriguez Panadero (Seville, Spain)
| |
Circulating d-Dimer lysozyme and angiotensin-converting enzyme in active sarcoidosis
S. Monti, P. Fazzi, F. Cocci, S. Troilo, S. Solfanelli, C. Giuntini (Pisa, Italy)
| |
Detection of Chlamydia pneumoniae and Mycoplasma pneumoniae in bronchial biopsy specimens
I. Y. Shumskaya, O. V. Lovacheva (Moscow, Russia)
| |